Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia-Reference-Cited by-同舟云学术

Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia

Published:2022-10 Issue: Volume:32 Page:100817
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Kim Eunjung^ORCID,Hwang Eo-Jin,Lee Junghye,Kim Dae-Young,Kim Jae-Young,Kim Dong-Wook

Publisher

Elsevier BV

Subject

Cancer Research

Reference61 articles.

1. Chronic myeloid leukaemia;Hehlmann;Lancet,2007

2. Chronic myeloid leukaemia as a model of disease evolution in human cancer;Melo;Nat Rev Cancer,2007

3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

4. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib;Gambacorti-Passerini;J Natl Cancer Inst,2011

5. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience;Kantarjian;Blood,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects;Hematological Oncology;2024-09

2. Treatment-Free Remission in Chronic Myeloid Leukemia;Journal of Clinical Medicine;2024-04-27

3. Computational modeling reveals key factors driving treatment-free remission in chronic myeloid leukemia patients;npj Systems Biology and Applications;2024-04-27

4. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels;Medical Oncology;2024-01-12

5. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-12